Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH.

J Clin Oncol. 1996 Jan;14(1):7-17.

PMID:
8558223
[PubMed - indexed for MEDLINE]
Free Article
2.

Studies of interferons in the therapy of melanoma.

Kirkwood JM.

Semin Oncol. 1991 Oct;18(5 Suppl 7):83-90. Review.

PMID:
1948134
[PubMed - indexed for MEDLINE]
3.

Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.

Kirkwood JM.

Eur J Cancer. 1998 Jul;34 Suppl 3:S12-7. Review.

PMID:
9849403
[PubMed - indexed for MEDLINE]
4.

Update on the role of adjuvant interferon for high risk melanoma.

Agarwala SS, Kirkwood JM.

Forum (Genova). 2000 Jul-Sep;10(3):230-9. Review.

PMID:
11007931
[PubMed - indexed for MEDLINE]
5.

Recent advances in the care of the patient with malignant melanoma.

Reintgen D, Balch CM, Kirkwood J, Ross M.

Ann Surg. 1997 Jan;225(1):1-14. Review.

PMID:
8998115
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.

Vaishampayan U, Abrams J, Darrah D, Jones V, Mitchell MS.

Clin Cancer Res. 2002 Dec;8(12):3696-701. Review.

PMID:
12473578
[PubMed - indexed for MEDLINE]
Free Article
7.

Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease.

Lens M.

Dermatol Ther. 2006 Jan-Feb;19(1):9-18. Review.

PMID:
16405565
[PubMed - indexed for MEDLINE]
8.

Is there a role for adjuvant high-dose interferon-alpha-2b in the management of melanoma?

Sabel MS, Sondak VK.

Drugs. 2003;63(11):1053-8. Review.

PMID:
12749732
[PubMed - indexed for MEDLINE]
9.

Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma.

Donnelly S.

Oncol Nurs Forum. 1998 Jun;25(5):921-7. Review.

PMID:
9644709
[PubMed - indexed for MEDLINE]
10.

Adjuvant therapy for high-risk primary and resected metastatic melanoma.

Hersey P.

Intern Med J. 2003 Jan-Feb;33(1-2):33-43. Review.

PMID:
12534876
[PubMed - indexed for MEDLINE]
11.

Cost effectiveness and cost utility of adjuvant interferon alpha in cutaneous melanoma: a review.

Crott R.

Pharmacoeconomics. 2004;22(9):569-80. Review.

PMID:
15209526
[PubMed - indexed for MEDLINE]
12.

[Adjuvant therapy of malignant melanoma].

Franke W, Neumann NJ, Ruzicka T, Schulte KW.

Praxis (Bern 1994). 2001 Feb 22;90(8):301-6. Review. German.

PMID:
11256332
[PubMed - indexed for MEDLINE]
13.

Intermediate- and high-risk melanoma.

Agarwala SS.

Curr Treat Options Oncol. 2002 Jun;3(3):205-17. Review.

PMID:
12057066
[PubMed - indexed for MEDLINE]
14.

The role of adjuvant therapy in melanoma management.

Barth A, Morton DL.

Cancer. 1995 Jan 15;75(2 Suppl):726-34. Review.

PMID:
7805001
[PubMed - indexed for MEDLINE]
15.

Melanoma. A multidisciplinary approach for the general surgeon.

Reeves ME, Coit DG.

Surg Clin North Am. 2000 Apr;80(2):581-601. Review.

PMID:
10836008
[PubMed - indexed for MEDLINE]
16.

[Clinical trial with intravesical alfa-2b interferon for the prevention of T1 transitional carcinoma of the bladder: preliminary results. Review of the bibliography].

Portillo Martín JA, Martín García B, Hernández Rodríguez R, Correas Gómez MA, Gutiérrez Baños JL, del Valle Schaan JI, Monge Mirallas JM, Roca Edreira A.

Arch Esp Urol. 1995 Jun;48(5):479-88. Review. Spanish.

PMID:
7639570
[PubMed - indexed for MEDLINE]
17.

Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.

Minutilli E, Feliciani C.

Tumori. 2012 Mar-Apr;98(2):185-90. doi: 10.1700/1088.11928. Review.

PMID:
22677983
[PubMed - indexed for MEDLINE]
18.

Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

Mocellin S, Pasquali S, Rossi CR, Nitti D.

J Natl Cancer Inst. 2010 Apr 7;102(7):493-501. doi: 10.1093/jnci/djq009. Epub 2010 Feb 23. Review.

PMID:
20179267
[PubMed - indexed for MEDLINE]
Free Article
19.

[Interferon therapy in malignant melanoma].

Kokoschka EM, Micksche M.

Wien Med Wochenschr. 1993;143(16-17):441-2. Review. German.

PMID:
8273369
[PubMed - indexed for MEDLINE]
20.

Current and future adjuvant immunotherapies for melanoma: blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach.

Agarwala SS, O'Day SJ.

Cancer Treat Rev. 2011 Apr;37(2):133-42. doi: 10.1016/j.ctrv.2010.06.001. Epub 2010 Jul 16. Review.

PMID:
20638184
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk